EU4Health is the EU’s funding programme to deliver on EU health policy and respond to the COVID-19 pandemic.
This call aims to reduce the burden of dementia and other neurological disorders in the Union, both at personal and population level, targeting or addressing the related risk factors and their determinants.
Neurological disorders (including dementia) are among the main sources of morbidity in the Union.
Neurological disorders are conditions characterised as being in or associated with the central or peripheral nervous system. Major non-communicable neurological disorders are Alzheimer’s disease, which is the main cause of dementia, and other forms of dementia, cerebrovascular diseases including stroke, Parkinson’s disease, multiple sclerosis, epilepsy, various headache disorders among which migraine, and traumatic brain injuries. Many more – both communicable and non-communicable – neurological disorders exist, often also with a substantial disease burden and premature mortality. These latter diseases are addressed in Union programmes and actions on rare diseases. Neurological disorders are the leading cause of disease burden in terms of Disability-Adjusted Life Years (DALYs) and second leading cause of deaths (2016). The four largest contributors of neurological DALYs in 2016 were stroke (42%), migraine (16%), Alzheimer’s disease and other dementias (10%), and meningitis (8%), the latter not being an NCD. As the prevalence of the major disabling neurological disorders steeply increases with age, there will be an increasing demand for treatment, rehabilitation and support services for neurological disorders in the coming years in all countries with ageing populations.
The aim of this action is to complement the implementation of the joint action “DP-g-23-33- 01 ‘Healthier Together’ EU NCD Initiative – Dementia and neurological disorders” led by the Member States, thus helping to reduce the burden of dementia and other neurological disorders in the Union, both at personal and population level, targeting or addressing the related risk factors and their determinants, as necessary.
The activities will cover the prevention and care of dementia and other neurological disorders, taking into account relevant results of Horizon 2020 projects94, and of relevant Horizon Europe projects, and will run in parallel to the joint action. Activities will include the implementation of projects involving civil society organisations to support the Member States’ authorities in implementing comprehensive public health policies, the development and transfer of best practices, the development of public health guidelines, the preparation and roll-out of innovative approaches and projects supporting patient pathway, and launching of projects, such as on training, health awareness and health literacy, that are expected to have a significant public health impact. Activities should also include an equity dimension and aim at reducing health inequalities.
The action will implement activities on health promotion and disease prevention and is expected to support the Member States’ efforts to reduce the burden of non-communicable diseases (approximately 80% of the disease burden in Europe), in particular that related to dementia and other neurological disorders, and to reach the Sustainable Development Goal 3, in particular target 3.4.
The expected results will include initiatives to complement the Member States’ efforts in the design, planning and implementation of best practices, such as for the development of public health guidelines, supporting patient pathways, and support for the preparation and roll-out of new policy approaches, participation in the pilot testing of innovative practices, development of support actions such as training and improving health awareness and health literacy.
Academia and educational institutions, civil society organisations supporting the priority areas (health professional associations, patient organisations, foundations, NGOs and similar entities).
Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions:
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
+ be legal entities (public or private bodies)
+ be established in one of the eligible countries, i.e.:
Expected duration of the project(s) in months: 36 months